XZB-0004

N/A

Report date: 2025/12/19 20:01:35
NME

Base Information

Drug NameXZB-0004
Drug Alias NameSLC-391XZB-0004SLC-0211
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAXL receptor tyrosine kinase inhibitors
TargetsAXL receptor tyrosine kinase
Therapy Area/IndicationsSolid tumoursFoodborne DiseasesMyelodysplastic Syndromes +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursFoodborne DiseasesMyelodysplastic Syndromes +[6
Inactive IndicationsLung Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A